Your browser doesn't support javascript.
The COVID-19 pandemic and the health of people who use illicit opioids in New York City, the first 12 months.
Bennett, Alex S; Townsend, Tarlise; Elliott, Luther.
  • Bennett AS; Department of Social and Behavioral Sciences, School of Global Public Health, New York University, United States; Center for Drug Use and HIV Research (CDUHR), School of Global Public Health, New York University, 708 Broadway, 6th Floor, New York, NY 10012, United States. Electronic address: asb19@nyu.edu.
  • Townsend T; Center for Drug Use and HIV Research (CDUHR), School of Global Public Health, New York University, 708 Broadway, 6th Floor, New York, NY 10012, United States; Center for Opioid Epidemiology and Policy, Department of Population Health, New York University Grossman School of Medicine, United States; Behavioral Science Training Program, NYU Rory College of Nursing, United States.
  • Elliott L; Department of Social and Behavioral Sciences, School of Global Public Health, New York University, United States; Center for Drug Use and HIV Research (CDUHR), School of Global Public Health, New York University, 708 Broadway, 6th Floor, New York, NY 10012, United States.
Int J Drug Policy ; 101: 103554, 2022 03.
Article in English | MEDLINE | ID: covidwho-1729687
ABSTRACT

BACKGROUND:

Concurrent opioid-related overdose and COVID-19 crises in the U.S. have imposed unprecedented challenges on people who use illicit opioids.

METHODS:

Using the experiences of 324 people who use illicit opioids between April 2020 and March 2021, we examined four domains of health and well-being potentially impacted by COVID-19 drug risks and responses, healthcare and related services, material hardship, and mental health. Data were drawn from participants' completed monthly survey assessments which were grouped into four periods of interest for the unfolding pandemic April-June 2020, July-October 2020, November-January 2021, and February-March 2021.

RESULTS:

A majority of measures in our four domains showed early COVID-19 related impacts, which quickly diminished as people and agencies responded to the pandemic. Difficulty obtaining food was the most frequently reported material hardship and appeared worst in April-June 2020. Over half of the population reported depression in April-June 2020, but this declined over the study period. Some participants reported changes to the heroin supply, including higher prices, lower quality, difficulty finding the drug, and fentanyl contamination. There was no discernable temporal shift in the frequency of use of each substance or the frequency of withdrawal symptoms. Over the study period, the mean number of overdoses per month decreased while the percent of opioid use events at which both a witness and naloxone were present (i.e., protected events) increased. Most participants receiving MOUD experienced an increase in take-home doses.

CONCLUSIONS:

Findings speak to the resilience of people who use drugs as a population with disproportionate experience of trauma and crisis and also to the rapid response of NYC health agencies and service providers working with this population. Despite evident signs of adaptability and resilience, the COVID-19 pandemic has highlighted some of the unique vulnerabilities of people who use illicit opioids and the need for greater rates of "protected" opioid use and greater availability of wrap-around services to efficiently address the safety, food security, mental health, and treatment needs of the population.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Drug Overdose / COVID-19 Type of study: Observational study / Prognostic study / Qualitative research Limits: Humans Country/Region as subject: North America Language: English Journal: Int J Drug Policy Journal subject: Public Health / Substance-Related Disorders Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Drug Overdose / COVID-19 Type of study: Observational study / Prognostic study / Qualitative research Limits: Humans Country/Region as subject: North America Language: English Journal: Int J Drug Policy Journal subject: Public Health / Substance-Related Disorders Year: 2022 Document Type: Article